Acute oxidative stress induced by ischemia-reperfusion or inflammation causes serious damage to tissues, and persistent oxidative stress is accepted as one of the causes of many common diseases including cancer. We show here that hydrogen (H2) has potential as an antioxidant in preventive and therapeutic applications. We induced acute oxidative stress in cultured cells by three independent methods. H2 selectively reduced the hydroxyl radical, the most cytotoxic of reactive oxygen species (ROS), and effectively protected cells; however, H2 did not react with other ROS, which possess physiological roles. We used an acute rat model in which oxidative stress damage was induced in the brain by focal ischemia and reperfusion. The inhalation of H2 gas markedly suppressed brain injury by buffering the effects of oxidative stress. Thus H2 can be used as an effective antioxidant therapy; owing to its ability to rapidly diffuse across membranes, it can reach and react with cytotoxic ROS and thus protect against oxidative damage.
Subscribe to Journal
Get full journal access for 1 year
only $18.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Wallace, D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39, 359–407 (2005).
Reddy, P.H. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J. Neurochem. 96, 1–13 (2006).
Ohta, S. A multi-functional organelle mitochondrion is involved in cell death, proliferation and disease. Curr. Med. Chem. 10, 2485–2494 (2003).
Wright, E., Jr ., Scism-Bacon, J.L. & Glass, L.C. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int. J. Clin. Pract. 60, 308–314 (2006).
Winterbourn, C.C. Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid. Toxicology 181, 223–227 (2002).
Chinopoulos, C. & Adam-Vizi, V. Calcium, mitochondria and oxidative stress in neuronal pathology. Novel aspects of an enduring theme. FEBS J. 273, 433–450 (2006).
Sauer, H., Wartenberg, M. & Hescheler, J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell. Physiol. Biochem. 11, 173–186 (2001).
Turrens, J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. (Lond.) 552, 335–344 (2003).
Sheu, S.S., Nauduri, D. & Anders, M.W. Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim. Biophys. Acta 1762, 256–265 (2006).
Liu, H., Colavitti, R., Rovira, I.I. & Finkel, T. Redox-dependent transcriptional regulation. Circ. Res. 97, 967–974 (2005).
Murad, F. Discovery of some of the biological effects of nitric oxide and its role in cell signaling. Biosci. Rep. 24, 452–474 (2004).
Buxton, G.V., Greenstock, C.L., Helman, W.P. & Ross, A.B. Critical review of rate constants for reactions of hydrated electrons, hydrogen atoms and hydroxyl radicals (•OH/•O-) in aqueous solution. J. Phys. Chem. Ref. Data 17, 513–886 (1988).
Ohsawa, I., Nishimaki, K., Yasuda, C., Kamino, K. & Ohta, S. Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells. J. Neurochem. 84, 1110–1117 (2003).
Setsukinai, K., Urano, Y., Kakinuma, K., Majima, H.J. & Nagano, T. Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J. Biol. Chem. 278, 3170–3175 (2003).
Tomizawa, S. et al. The detection and quantification of highly reactive oxygen species using the novel HPF fluorescence probe in a rat model of focal cerebral ischemia. Neurosci. Res. 53, 304–313 (2005).
Kamiya, H. Mutagenicities of 8-hydroxyguanine and 2-hydroxyadenine produced by reactive oxygen species. Biol. Pharm. Bull. 27, 475–479 (2004).
Petersen, D.R. & Doorn, J.A. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic. Biol. Med. 37, 937–945 (2004).
Falick, A.M., Mahan, B.H. & Myers, R.J. Paramagnetic resonance spectrum of the 1Δg oxygen molecule. J. Chem. Phys. 42, 1837–1838 (1965).
Asoh, S. et al. Protection against ischemic brain injury by protein therapeutics. Proc. Natl. Acad. Sci. USA 99, 17107–17112 (2002).
Halestrap, A.P. Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem. Soc. Trans. 34, 232–237 (2006).
Lipton, P. Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431–1568 (1999).
Ferrari, R. et al. Oxidative stress during myocardial ischaemia and heart failure. Curr. Pharm. Des. 10, 1699–1711 (2004).
Nito, C., Kamiya, T., Ueda, M., Arii, T. & Katayama, Y. Mild hypothermia enhances the neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats. Brain Res. 1008, 179–185 (2004).
Takada, J. et al. Adenovirus-mediated gene transfer to ischemic brain is augmented in aged rats. Exp. Gerontol. 38, 423–429 (2003).
Zhang, N. et al. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 36, 2220–2225 (2005).
Labiche, L.A. & Grotta, J.C. Clinical trials for cytoprotection in stroke. NeuroRx 1, 46–70 (2004).
Murakami, K. et al. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J. Neurosci. 18, 205–213 (1998).
Ito, D. et al. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res. Mol. Brain Res. 57, 1–9 (1998).
Bjelakovic, G., Nikolova, D., Gluud, L.L., Simonetti, R.G. & Gluud, C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. J. Am. Med. Assoc. 297, 842–857 (2007).
James, A.M., Cocheme, H.M. & Murphy, M.P. Mitochondria-targeted redox probes as tools in the study of oxidative damage and ageing. Mech. Ageing Dev. 126, 982–986 (2005).
Fontanari, P. et al. Changes in maximal performance of inspiratory and skeletal muscles during and after the 7.1-MPa Hydra 10 record human dive. Eur. J. Appl. Physiol. 81, 325–328 (2000).
This work was supported by grants to S.O. from the Ministry of Health, Labor and Welfare (H17-Chouju-009, longevity science; and 17A-10, nervous and mental disorders) and the Ministry of Education, Culture, Sports, Science and Technology (16390257).
The authors declare no competing financial interests.
Molecular hydrogen dissolved in culture medium does not reduce cellular hydrogen peroxide and nitric oxide. (PDF 351 kb)
pH, H2 and O2 maintain constant in culture medium in a closed flask filled with a mixed gas. (PDF 75 kb)
Several methods confirm protection of cells by H2 against oxidative stress. (PDF 470 kb)
Molecular hydrogen protects cultured neurons from ischemia and reperfusion in vitro. (PDF 553 kb)
Cerebral blood flow is not influenced by H2 inhalation. (PDF 417 kb)
The brain after induction of ischemia reperfusion injury with or without H2 treatment was immunostained. (PDF 305 kb)
Physiological parameters during cerebral ischemia reperfusion (PDF 255 kb)
About this article
Cite this article
Ohsawa, I., Ishikawa, M., Takahashi, K. et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 13, 688–694 (2007). https://doi.org/10.1038/nm1577
Inhaled molecular hydrogen attenuates intense acute exercise-induced hippocampal inflammation in sedentary rats
Neuroscience Letters (2020)
ACS Applied Materials & Interfaces (2020)
Bioscience Reports (2020)
ACS Biomaterials Science & Engineering (2020)
Effects of Hydrogen-rich Water on the PI3K/AKT Signaling Pathway in Rats with Myocardial Ischemia-reperfusion Injury
Current Molecular Medicine (2020)